Roles of Exosomal miRNAs in Asthma: Mechanisms and Applications
Xiaoxue Liu,Jiawei Gao,Liuxin Yang,Xingxing Yuan
DOI: https://doi.org/10.2147/jaa.s485910
2024-09-30
Journal of Asthma and Allergy
Abstract:Xiaoxue Liu, 1 Jiawei Gao, 2 Liuxin Yang, 2 Xingxing Yuan 2, 3 1 Department of Paediatrics, Harbin Hospital of Traditional Chinese Medicine, Harbin, 150010, People's Republic of China; 2 Heilongjiang University of Chinese Medicine, Harbin, 150040, People's Republic of China; 3 Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, 150006, People's Republic of China Correspondence: Xingxing Yuan, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People's Republic of China, Email Asthma is a chronic inflammatory disorder of the airways, characterized by a complex interplay of genetic, environmental, and immunological factors that contribute to its onset and progression. Recent advances in researches have illuminated the critical role of exosomal microRNAs (miRNAs) in the pathogenesis and development of asthma. Exosomes are nano-sized extracellular vesicles that facilitate intercellular communication by transporting a variety of bioactive molecules, including miRNAs, and play a crucial role in regulating gene expression and immune responses, which are central to the inflammatory processes underlying asthma. Exosomal miRNAs are emerging as key players in asthma due to their involvement in various aspects of the disease, including the regulation of inflammation, airway hyperresponsiveness, and remodeling. Their ability to influence the behavior of target cells and tissues makes them valuable both as diagnostic biomarkers and as potential therapeutic targets. This review aims to provide a comprehensive overview of the biogenesis of exosomes, the functional roles of exosomal miRNAs in asthma, and their clinical potential. It will explore the mechanisms by which these miRNAs contribute to asthma pathophysiology, discuss their utility in diagnosing and monitoring the disease, and highlight ongoing research efforts to harness their therapeutic potential. Keywords: asthma, exosome, miRNA, biomarker, therapy Asthma is a prevalent chronic respiratory disease that affects over 300 million individuals worldwide. It is characterized by episodic airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation of the airways. 1,2 Symptoms include wheezing, shortness of breath, chest tightness, and coughing, which can vary in intensity and frequency. 3 Despite advances in understanding the pathophysiology of asthma and the development of new therapeutic strategies, there remain significant gaps in effective disease management, especially for patients with severe asthma. 4 Asthma is a heterogeneous disease with various phenotypes, driven by complex interactions between genetic predisposition and environmental factors. 5,6 This complexity necessitates the need for personalized approaches to diagnosis and treatment. Recent studies have increasingly focused on the role of extracellular vesicles (EVs) in asthma, particularly exosomes, which are small, nano-sized vesicles (30–150 nm in diameter) that originate from the endosomal compartment of cells. 7,8 They are released into the extracellular environments when multivesicular bodies fuse with the plasma membrane, and carry a cargo of proteins, lipids, and nucleic acids, including microRNAs (miRNAs), which are short non-coding RNA molecules that regulate gene expression at the post-transcriptional level. 9,10 MiRNAs are involved in various biological processes, including development, differentiation, proliferation, and apoptosis. 11 Dysregulation of miRNAs has been implicated in a range of diseases, including cancer, cardiovascular diseases, and inflammatory conditions such as asthma. 12 In asthma, exosomal miRNAs have emerged as key regulators of immune responses and airway remodeling. They facilitate communication between different cell types within the airway microenvironment, including epithelial cells, immune cells, and fibroblasts, which are crucial for the initiation and propagation of inflammatory responses and for maintaining tissue homeostasis. 13–15 For instance, exosomal miRNAs have been shown to influence the differentiation and activation of various immune cell subsets, such as T lymphocytes, B cells, and macrophages, thereby shaping the immune landscape of this disease. 16–18 Given their stability in biological fluids and their ability to reflect the physiological state of parent cells, exosomal miRNAs hold great promise as non-invasive biomarkers for asthma. 19 Thus, profiling exosomal miRNAs could improve early diagnosis, monitor disease activity, and predict treatment responses, thereby enabling more precise and personalized management of asthma. Compared to other relevant review papers,<sup -Abstract Truncated-
immunology,allergy,respiratory system